Catalyst Wire Dossier Catalyst Wire Dossier

Diatrizoate Meglumine and Diatrizoate Sodium

diatrizoate meglumine and diatrizoate sodium · Guardian Drug Company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Diatrizoate Meglumine and Diatrizoate Sodium, covering 2022-06-27 to 2023-11-17. Get the full timeline:

Most recent: FDA Approved: DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM — Original Application (Camber Pharmaceuticals, Inc.)

See pricing